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147 Categorization of patients by “Leeds criteria” for Pseudomonas
aeruginosa infection in cystic ﬁbrosis center in Republic of
Macedonia
T. Jakovska-Maretti, S. Fustik, L. Spirevska. University Pediatric Clinic, Skopje,
Macedonia
Patients with cystic ﬁbrosis were deﬁned by Lee deﬁnition for Pseudomonas
aeruginosa infection in four categories. “Chronic” when more than 50% of the
preceding 12 months were PA culture positive, “intermittent” when 50% of the
preceding 12 months were PA culture positive, “free of PA” with no growth of PA
for the previous 12 months, having previously been PA culture positive, or “never
infected”, when PA had never been cultured. The aim of the study was to identify the
CF patients in adequate groups and asses relationship with clinical, immunological
and lung function parameters.
Methods: The study included 76 children and adolescents (61 males) with mean
age 8, 7±6, 9 SD years, who regularly attend the Cystic Fibrosis Center in
R. Macedonia. Clinical and demographic data was collected as near as possible
to the end of the 12-month period.
Results: The “chronic” group (18% of the patients) had signiﬁcantly worse
Shwachman-Kulczycki (SK) and Crispin-Norman chest x-ray scores than the “inter-
mittent” (31%) and “free” (29%) categories (p< 0.008). We didn’t ﬁnd signiﬁcant
correlation for % predicted FEV1 value and BMI between the groups (p = 0.6).
“Chronic” patients were signiﬁcantly associated with a positive, and “never patients”
with a negative PA antibody result (p = 0.05).
Conclusions: Previous deﬁnitions may over-estimate the prevalence of chronic PA
infection in CF patients.
148 Pseudomonas aeruginosa infection: utility of microbiological,
PCR-based and serological techniques
J. Brazova, D. Zemkova, S. Vosahlikova, O. Nyc, P. Pohunek, V. Vavrova. Cystic
Fibrosis Centre, UH Motol and Charles University, Prague, Czech Republic
Within 2004–2006 we had studied the utility of microbiological, molecular genetic
and serological techniques for the early detection of Pseudomonas aeruginosa (PA)
and Burkholderia cepacia (BC) at our centre. 224 patients were examined using
microbiological and PCR techniques, combined with speciﬁc anti-PA antibodies
(ELISA).
Cases: (a) PA negative (PAN, n = 43), (b) PA intermittent positive (PAI, n = 40),
(c) PA chronic colonization (PAC, n = 42), (d) PA free (PAF n = 42) and (e) BC-
positive cases (n = 57). Markedly lower FEV1 was found in the oldest BC group
(69.1+25.4% p.v.) and in PAC cases (73.6+26.1). This is signiﬁcantly less than in
PAN (95.9+17.2) and PAF (87.8+20.2) cases. PAI differ signiﬁcantly only from
the BC group (84.7+21.3), while in BC, PAC and PAF groups deterioration in
adults was observed. During the study frequency of analyzed sputa has increased,
thus more patients were classiﬁed as PAC. On the other hand, the age of PAI
patients has increased from 10.7+5.7 yrs to 13.6+6.1 (p< 0.05) and lung function
has not deteriorated. In PA microbial cultivation correlated with PCR positivity
(p< 0.001). As expected, most of the discordant results were within the PAI
group. Correlation between serology and cultivation/PCR positivity was strong
(p< 0.0001). Concordant results were found only in PAC and PAN groups. In
the PAN group only negative or borderline antibody titres were found. Negative
antibody titres did not exclude PA infection. In summary, we proved that regular/
frequent sputum examinations, supplemented with serological testing, facilitate
early pathogen detection and prevent lung function deterioration.
Supported by: IGA NR7974−3, NR8458−5 and VZ 64203.
149 Early warning signs of bacterial exacerbation in cystic ﬁbrosis
patients
H.A. Jimenez, A.A. Vergara, E. Aquino, R.A. Oliveira, F.C. Reis. CF Association
of Minas Gerais, Belo Horizonte, MG, Brazil
One of the goals of the multidisciplinary team of the CF Association of Minas
Gerais, Brazil is to preserve lung tissue from bacterial exacerbation in cystic ﬁbrosis
patients.
The objective of this study is to ﬁnd out if there are clues that bacterial exacerbation
are coming on. To our knowledge there are no studies to identify the early warning
signs among CF patients. We want to know if these patients have early warning
signs before installation of fever and/or breathing difﬁculties.
The study was carried out by telephone interview among the 300 registered CF
patients in the Association, by a physiotherapist student who did not know the
patients and she just asked two questions. First question was related to the use of
antibiotics during the year of 2006. The second question was asked if patients or
their parents have noticed something different before the patients have fever.
Until now there were 57 patients that have used antibiotics during 2006 and have
fever, representing only 17% of the total registered patients.
The preliminary results of this questionnaire pointed out these early warning signs*:
get tired and quiet (16/57); increase cough (11/57); lack of appetite (11); sticky
sputum (11); sleepy (4); headache (3); get excited, nervous (3); crybaby (2); dry
mouth (1); pale (1); clammy (1); difﬁcult to walk (1); red eyes (1); itchy throat (1)
and abdominal pain (1). (Number of patients listed in parentheses.)
It is helpful to know these early warning signs. We assume that the earlier the
diagnosis of exacerbation is made, the easier it is to reverse the problem and less
destruction of the lung tissues.
* Lung Line, National Jewish Center for Immunology and Respiratory Medicine
1988.
Supported by: CF Association of Minas Gerais, Brazil.
150 Prevalence of nontuberculous mycobacteria in a Czech Cystic
Fibrosis centre
A. Holcikova1, I. Binkova2, J. Svobodova3. 1Infectious Disease, FN Brno, Brno,
Czech Republic; 2Pulmonology, FN Brno, Brno, Czech Republic; 3Microbiology,
FN Brno, Brno, Czech Republic
Background: Patients with Cystic Fibrosis (CF) are at high risk for acute and
chronic airway infections. We inquire sputum for possible bacteriological infection
in CF patients routine every month. Nontuberculous mycobacteria (NTM) are po-
tential pathogens in CF patients and they may worse chronic pulmonary disease and
nutritional failure. Czech population is obligatory vaccinated against tuberculosis.
BCG vaccination partly protects versus NTM.
Aim: The aim of the present work of this study was to assess the prevalence of
NTM among CF patients.
Methods: They were 55 CF patients cured in a regional CF centre in University
hospital in Brno in 2006, 36 children and 19 adults We collected sputum or aspirate
from trachea and processed for mycobacterial smear and culture. Special cultivation
technique was used in CF sputum.
Results: In opposite from others CF centres we did not ﬁnd any positive ﬁnding
for NTM in our CF patients.
Conclusion: The prevalence of NTM in CF is low. Non ﬁndings in our group can
indicate that the studied group of patients is a small one or that BCG vaccination
may prevent NTM colonisation in our patients also. An assessment for NTB
minimally ones a year is involved in guidelines for CF care in Czech Republic
in this year.
We dare to argue that BCG vaccination can be a proﬁt for CF patients.
